HOME >> BIOLOGY >> NEWS
Budding viral hijackers may co-opt cell machinery for the getaway

When retroviruses like HIV infect cells, they take over the cell's machinery to manufacture new copies of themselves. Research published this week in the top-tier open access journal, Journal of Biology, shows that to escape from cells, retroviruses may once again hijack cellular components, in this case molecules normally used to engulf material from the cell's surroundings in a pocket formed from cell membrane. The findings, offer new insights into how viruses propagate and cause disease, and how healthy cells work.

Retroviruses travel from cell to cell in 'spacecraft' surrounded by the membrane of host cells. These transporters protect the virus from attack by the immune system, as they disguise the virus as part of the body. The outer membrane of the virus particle also helps the virus to spread, as it can fuse with the membrane of other vulnerable cells.

During the construction of a virus particle, or virion, the cell membrane bulges outwards, engulfing viral components as it goes. One of the viral proteins, called Gag, is essential for this process.

Now, researchers from Columbia and Yale Universities, USA, Aijou University, South Korea and the Chinese Academy of Sciences has shown that some retroviral Gag proteins bind tightly to a host-cell protein called endophilin-2. Endophilin-2 is normally involved in the inward budding of the cell membrane, a process known as endocytosis.

Supporting the idea that this interaction is functionally relevant, the researchers found endophilin-2 inside viral particles that had budded from cells infected with Moloney-murine leukaemia virus. On further examination, they also found two other proteins involved in endocytosis, a-adaptin and clathrin, inside the virions. However, Dynamin-2, a protein that binds to endophilin-2, was not there. This suggests that the incorporation of selected proteins is unlikely to be accidental.

Endophilin-2's normal role is to increase the curvature of the
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-0-20-7323-0323
BioMed Central
3-Dec-2003


Page: 1 2

Related biology news :

1. Poetically Timed With Spring, Budding Yeast Yield Possible Insight Into Male Fertility--And Infertility
2. First glimpse of DNA binding to viral enzyme
3. X marks the spot: Vector insertion is viral specific
4. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
5. Researchers develop better understanding of immune response to viral infection
6. New papillomavirus target could lead to specific antiviral drugs for precancerous cervical lesions
7. Sick Kids researchers look at viral triggers for multiple sclerosis in children
8. The catch 22 of immune response to AIDs viral infection
9. A viral cure for type 1 diabetes
10. Purdue biologists expose the inner workings of viral machine
11. Retroviral protein triggers proliferation of immune cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, Inc. announced ... that provides patent development support for early stage startups. The investment will support ... ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical technology. , ...
(Date:4/18/2020)... ... April 16, 2020 , ... SIRION Biotech GmbH , a world ... it will present a company update on its work expediting gene therapy research and ... on April 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, will also ...
(Date:4/16/2020)... , ... April 15, 2020 , ... ... working cell banks and hMSC bioprocess systems, announces that the Medical Technology Enterprise ... at MTEC’s 4th Annual Membership Meeting in March. The Regenerative Medicine (RegenMed) biomanufacturing ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... ... May 05, 2020 , ... Smart Meter, ... of its iGlucose® LTE Cat-M Cellular Connected Diabetes Blood Glucose Monitor ... the industry’s newest and broadest cellular connectivity available, to provide patients with seamless ...
(Date:4/26/2020)... ... April 23, 2020 , ... Indegene Omnipresence, Inc. ... providing applications and services for use on Microsoft Azure. The customer experience management ... up online for a built-for-purpose customer engagement capability to use in their commercial ...
(Date:4/22/2020)... , ... April 20, 2020 , ... ... in Cambridge, MA, announced today that Omixon’s founder and chairman Dr. Attila Berces ... Omixon’s flagship product Holotype HLA since 2014 before stepping into the CEO role ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... continue their work through COVID-19. Many clinical trial teams are working remotely and ... Ripple Science wants to help researchers continue their research during this uncertain time ...
Breaking Biology Technology:
Cached News: